[5]
AlOthman, Z.A.; Rahman, N.; Siddiqui, M.R. Review on pharmaceutical impurities, stability studies and degradation products. Rev. Adv. Sci. Eng., 2013, 2, 155-166.
[6]
Rahman, N.; Azmi, S.N.H.; Wu, H.F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit. Qual. Assur., 2006, 11, 69-74.
[7]
Rahman, N.; Haque, S.M.; Hossain, S.M.Z. Rapid and simple spectrophotometric analysis of labetalol hydrochloride in pharmaceutical, urine and blood samples. Can. Chem. Trans., 2013, 1, 66-77.
[8]
Rahman, N.; Anwar, N.; Kashif, M.; Hoda, M.N.; Rahman, H. Determination of labetalol hydrochloride by kinetic spectrophotometry using potassium permanganate as oxidant. J. Mex. Chem. Soc., 2011, 55, 105-112.
[9]
Rahman, N.; Haque, S.K. Spectrofluorimetric determination of labetalol hydrochloride in pharmaceutical preparations and urine samples. Int. J. Biomed. Anal, 2008, 4, 140-146.
[13]
Zhao, H.; Li, H.; Qiu, Z. Separation of enantiomeric labetalol by reverse-phase high performance liquid chromatography. Chin. J. Chromatogr., 1999, 17, 369-371.
[20]
Tamisier-Karolak, S.L.; Stenger, M.A.; Bommart, A. Enantioseparation of β-blockers with two chiral centers by capillary electrophoresis using sulfated β-cyclodextrins. Electrophoresis, 1999, 20, 2656-2663. DOI: 10.1002/(SICI)1522-2683(19990901)20: 13<2656::AID-ELPS2656>3.0.CO;2-6
[24]
Radi, A.; El-Sherif, Z.; Wassel, A. Voltametric determination of labetalol in pharmaceuticals and spiked human urine. Chem. Pap., 2004, 58, 242-246.
[25]
Gilman, A.G.; Rall, T.W.; Nies, A.S.; Taylor, P., Eds.; The Pharmacological Basis of Therapeutics; 8th Ed., Pergamon Press, Oxford, 1990, p. 286, 847.
[27]
Manzoor, A.; Manohara, Y.N.; Ravi, M.C. Development and validation of RP-HPLC method for simultaneous estimation of nebivolol hydrochloride and hydrochlorothiazide in combined tablet dosage form. Int. J. Chemtech Res., 2012, 4(1), 328-336.
[28]
Patel, S.A.; Patel, H.M. Development and Validation of HPTLC Method for Simultaneous Estimation of Nebivolol and Hydrochlorothiazide in Tablet. IJPFR, 2012, 2(1), 28-38.
[29]
Tarte, P.S.; Wate, S.P.; Khedikar, P.B.; Sapture, B.T.; Pawnikar, G. Simultaneous estimation of nebivolol and hydrochlorothiazide in combined tablet dosage form by multicomponent mode of analysis. Asian J. Res. Chem, 2008, 1(2), 77-79.
[30]
Shah, K.; Desai, T.R.; Behera, A.; Pal, R.S.; Girhepunje, K.M. Development of spectrophotometric methods for estimation of nebivolol hydrochloride and hydrochlorothiazide simultaneously in bulk and tablet dosage form. Res. J. Pharm. Biol. Chem. Sci., 2010, 1(2), 451-457.
[31]
Shah, K.V.; Tirgar, P.R.; Sheth, D.B.; Desai, T.R. Simultaneous estimation of nebivolol hydrochloride and hydrochlorothiazide in bulk and in a tablet dosage form by multicomponent and simultaneous estimation method. Int. J. Pharm., 2011, 2(1), 27-35.
[32]
Patel, R.K.; Patel, J.B. Simultaneous equation spectrophotometric method for the estimation of nebivolol HCl and hydrochlorothiazide in their combined dosage form. IRJPAS, 2011, 2(1), 6-10.
[33]
Patel, R.K.; Patel, J.B. Absorbance ratio spectrophotometric method for the estimation of nebivolol HCL and hydrochlorothiazide in their combined dosage form. IJAPBC, 2012, 1(4), 496-502.
[34]
Sweetman, S.C.; Pharm, B.; Pharms, F.R. Martindale, “the Complete Drug Reference”; 36th ed, the pharmaceutical press, London, UK, 2009, p. 1307-1311.
[35]
Kumbhar, S.T.; Chougule, G.K.; Tegeli, V.S.; Gajeli, G.B.; Thorat, Y.S.; Shivsharan, U.S. A validated HPTLC method for simultaneous quantification of nebivolol and hydrochlorothiazide in bulk and tablet formulation. IJPSDR, 2011, 3(1), 62-66.
[36]
Tarte, P.S.; Wate, S.P.; Bondre, A.V.; Paunikar, G.V. Simultaneous determination of nebivolol and hydrochlorothiazide in tablet dosage form by RP-HPLC. Int. J. of Pharm. Tech. Res., 2009, 1(3), 720-724.
[37]
Ivanović, D.; Medenica, M.; Jančić, B.; Knežević, N.; Malenović, A.; and Milić, J. Validation of an analytical procedure for simultaneous determination of hydrochlorothiazide, lisinopril and their impurities. Acta Chromatogr., 2007, 18, 143-156.
[38]
Foda, N.H.; Naeem, O. Abd ELbary, A. and Abd ELbary, G. Simultaneous HPLC determination of Enalapril and Hydrochlorothiazide in Human Plasma and its pharmacokinetic application. Int. J. Pharm. Sci. Res., 2010, 2(11), 786-794.
[40]
Obando, M.A.; Estela, J.M.; Cerdà, V. Simultaneous determination of hydrochlorothiazide and losartan potassium in tablets by high-performance low-pressure chromatography using a multi-syringe burette coupled to a monolithic column. Anal. Bioanal. Chem., 2008, 391(6), 2349-2356.
[42]
U.S. Pharmacopoeia, 39th ed., U.S. Pharmacopeial Convention, Inc., Rockville, MD, 2016, pp. 4624-4628.
[43]
Hemke, A.T.; Bhure, M.V.; Chouhan, K.S. Gupta; K.R. and Wadodkar, S.G. UV Spectrophotometric Determination of Hydrochlorothiazide and Olmesartan Medoxomil in Pharmaceutical Formulation. E-J. Chem., 2010, 7(4), 1156-1161.
[46]
Company method supplied by El-debiky, Co. Cairo, Egypt by personal communications.
[47]
Company method supplied by Marcyrl, Co. Cairo, Egypt by personal communications.
[49]
Mohesen, A.M.; Lotfy, H.M.; Badawey, A.M.; Salem, H.; Elkhateeb, S.Z. Application of three novel spectrophotometric methods manipulating ratio spectra for resolving a pharmaceutical mixture of chlorphenoxamine hydrochloride and caffeine. Int. J. Pharm. Pharm. Sci., 2013, 5(1), 487-487.
[51]
Afkhami, A.; Bahram, M. Mean centering of ratio spectra as a new spectrophotometric method for the analysis of binary and ternary mixtures. Talanta, 2005, 66, 712-720.
[52]
Kramer, R. Chemometric Techniques for Quantitative Analysis; Marcel Dekker Inc: New York, NY, 1998.
[54]
Olivieri, A.C.; Faber, N.M.; Ferre, J.; Boque, R.; Kalivas, J.H.; Mark, H. Guidelines for calibration in analytical chemistry Part 3. Uncertainty estimation and figures of merit for multivariate calibration. Pure Appl. Chem., 2006, 78(3), 633-650.
[55]
ICH Validation of analytical procedures: text and methodology Q2 (R1), International Conference on Harmonization, 2005.